Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

Sci Rep. 2024 Jan 20;14(1):1812. doi: 10.1038/s41598-024-52357-0.

Abstract

Alagille Syndrome (ALGS) is a complex genetic disorder characterized by cholestasis, congenital cardiac anomalies, and butterfly vertebrae. The variable phenotypic expression of ALGS can lead to challenges in accurately diagnosing affected infants, potentially resulting in misdiagnoses or underdiagnoses. This study highlights novel JAG1 gene mutations in two cases of ALGS. The first case with a novel p.Pro325Leufs*87 variant was diagnosed at 2 months of age and exhibited a favorable prognosis and an unexpected manifestation of congenital hypothyroidism. Before the age of 2, the second patient was incorrectly diagnosed with liver structural abnormalities, necessitating extensive treatment. In addition, he exhibited delays in language acquisition that may have been a result of SNAP25 haploinsufficiency. The identification of ALGS remains challenging, highlighting the importance of early detection and genetic testing for effective patient management. The variant p.Pro325Leufs*87 is distinct from reported variants linked to congenital hypothyroidism in ALGS patients, thereby further confirming the clinical and genetic complexity of ALGS. This emphasizes the critical need for individualized and innovative approaches to diagnosis and medical interventions, uniquely intended to address the complexity of this syndrome.

Publication types

  • Case Reports

MeSH terms

  • Alagille Syndrome* / diagnosis
  • Alagille Syndrome* / genetics
  • China
  • Congenital Hypothyroidism* / genetics
  • Genetic Testing
  • Humans
  • Infant
  • Jagged-1 Protein / genetics
  • Male

Substances

  • JAG1 protein, human
  • Jagged-1 Protein